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ABSTRACT
Convenient and well-performing protein detection
methods for a wide range of targets are in great
demand for biomedical research and future diag-
nostics. Assays without the need for washing steps
while still unaffected when analyzing complex bio-
logical samples are difficult to develop. Herein, we
report a well-characterized nucleic acid proximity-
based assay using antibodies, called Proximity
Extension Assay (PEA), showing good performance
in plasma samples. Target-specific antibody pairs
are linked to DNA strands that upon simultaneous
binding to the target analyte create a real-time PCR
amplicon in a proximity-dependent manner enabled
by the action of a DNA polymerase. 30Exonuclease-
capable polymerases were found to be clearly su-
perior in sensitivity over non-30exonuclease ones. A
PEA was set up for IL-8 and GDNF in a user-friendly,
homogenous assay displaying femtomolar detec-
tion sensitivity, good recovery in human plasma,
high specificity and up to 5-log dynamic range in
1kL samples. Furthermore, we have illustrated the
use of a macro-molecular crowding matrix in com-
bination with this homogeneous assay to drive target
binding for low-affinity antibodies, thereby improv-
ing the sensitivity and increasing affinity reagent
availability by lowering assay development depend-
ency on high-affinity antibodies. Assay performance
was also confirmed for a multiplex version of PEA.
INTRODUCTION
Detection and quantiﬁcation of proteins in complex bio-
logical samples can pose several technical challenges.
Assay performance as of recovery, speciﬁcity and linearity
can especially be negatively affected. The homogenous
proximity ligation assay (PLA) has been shown to
provide sensitive protein detection in very small sample
volumes (1,2). PLA is based on the analyte becoming
bound by two so called proximity probes which are anti-
bodies coupled with DNA strands, and when these strands
come in close proximity upon by target binding they are
united through the activity of a DNA ligase enzyme. The
newly formed joint ligation product then serves as a
template for quantitative PCR reﬂecting the amount of
target protein present. As this assay is homogeneous,
meaning no washing steps, all the components of the sam-
ple are present throughout the assay. Such components
might interfere with the assay and lower the efﬁciency of
the enzymatic processes involved, thereby impairing assay
recovery. The use of DNA ligases for PLA has proven
difﬁcult in human plasma requiring data normalization
(3). Therefore, we investigated the use of DNA polymer-
ases to improve homogenous nucleic acid proximity reac-
tions when using biological samples. A few previous
reports have used DNA polymerase-based proximity as-
says (4–6). However, those assays were not based on anti-
bodies, nor were their analyses performed on human
plasma samples, and only modest low pM sensitivity
was reported.
In endeavors to develop a wider range of sensitive pro-
tein detection assays ultimately covering the entire human
proteome, suitable afﬁnity reagents are lacking. Antibody
afﬁnities vary greatly with different target antigens and
different batches. This directly affects assay performance
as of sensitivity and causes prolonged assay development
time in a search for better antibodies. In an attempt to
enable the use of antibodies of lower afﬁnities in proximity
extension assay (PEA), we sought to use a water exclusion
matrix to drive target analyte binding by increasing the
effective concentration of the PEA probes by the use of
sephadex bead expansion (7).
MATERIALS AND METHODS
Plasma samples, antigen standards and antibodies
EDTA blood samples were collected from healthy subjects.
The samples were centrifuged at 2500g for 10min at 4 C.
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and stored at  20 C. All polyclonal antibody (Ab) and
their respective recombinant human proteins were
purchased from RnD Systems, besides CA19-9 that was
a kind gift from Fujirebio Diagnostics AB. Recombinant
proteins were all reconstituted in PBS +0.1% BSA and
stored at  80 C.
Proximity probes and antigen standards
Proximity probes were prepared by covalently linking a
single batch of afﬁnity-puriﬁed polyclonal antibody or
matched monoclonal antibody pairs to 30-hydroxyl free
and 50-phosphate free 40-mer oligonucleotide sequences.
These antibody-oligonucleotide conjugates were generated
by Innova Biosciences (Cambridge, UK) using their
Lightning-Link
TM technology. Conjugation quality was
analyzed by SDS–PAGE (data not shown). The 40-mer
30 and 50 oligonucleotide sequences used for the antibody
conjugation comprised a 20-bp universal sequence used as
hybridization site and target for the Molecular Beacon (8),
and a unique 20-bp sequence for primer targeting in
qPCR. The extension primer was hybridized to the
50-free oligonucleotide of one of the proximity probe con-
jugates, at a 2:1 oligo-to-Ab ratio. All sequences used are
reported in (Supplementary Table S1).
Proximity extension assay
One microliter sample (PBS+0.1% BSA buffer±antigen
spike or human EDTA plasma) was mixed with 1ml pla-
sma dilution buffer (Olink Bioscience, Sweden). Samples
were incubated at 25 C for 20min. To these samples, 2ml
of probe mix [25mM Tris–HCl, 4mM EDTA, 0.016mg/ml
single-stranded salmon sperm DNA (Sigma Aldrich),
0.02% sodium azide and 100pM of each PEA conjugate]
was added and incubated at 37 C for 1h.
After the probe incubation, the samples were trans-
ferred to a thermal cycler and put on hold at 37 C. An
amount of 76ml of dilution mix containing 70.5mM Tris–
HCl, 17.7mM ammonium sulfate, 1.05mM dithiothreitol
and 40mM of each dNTP’s were added. After a 5-min
incubation at 37 C, a 20ml extension mix containing
66.8mM Tris–HCl, 16.8mM ammonium sulfate, 1mM
dithiothreitol, 33mM magnesium chloride, 62.5U/ml T4
DNA Polymerase [or 62.5U/ml Klenow fragment exo( ),
125U/ml Klenow fragment, 125U/ml DNA Polymerase I
(Fermentas), 250U/ml Exonuclease I (New England
Biolabs)] was added. The extension reactions were run at
37 C for another 20min followed by a 10-min heat-
inactivation step at 80 C.
Sephadex G100 experiments were performed as above,
but using incubation tubes containing 500mg of lyophil-
ized sephadex G100 at the bottom. Sephadex G100
(Pharmacia) was resolved at 2.5 w/v% in 20% EtOH,
and kept shaking at 200rpm at room temperature (RT)
for at least 24h. Before each experiment, 20ml of the
sephadex G100 slurry was added per well and lyophilized
using a SpeedVac SPD1010 (Thermo Scientiﬁc), 60min at
65 C and 10torrs.
PEA was also performed in multiplex using the 23-plex
panels given in Supplementary Table S1. All steps were
performed as above, but using a set of 23 unique probe
oligo pairs, 23 corresponding extension primers and 23
unique primer pairs for qPCR detection and a universal
molecular beacon probe for detection (Supplementary
Table S1). Each multiplex PEA sample was split across
the individual qPCRs readouts each using a target-speciﬁc
primer pair.
Detection by quantitative PCR
For the qPCR detection, 4ml of the extension products
was transferred to a qPCR plate and mixed with 6ml
qPCR mix; 25mMTris–HCl, 7.5mM magnesium chloride,
50mM potassium chloride, 8.3mM ammonium sulfate,
8.3% Trehalose (Acros Organics), 333mM (each)
dNTP’s, 1.67mM dithiothreitol, 833nM of each primer
(forward: 50-TCGTGAGCCCAAGTGTTAATTTGCTT
CACGA-30 and reverse: 50-TGCAGTCTGTAGCGAAG
TTCTCATACTGCA-30; or the hairpin primers forward:
50-TCGTGAGCCCAAGTGTTAATTTGCTTCACGA-30
and reverse 50-TGCAGTCTGTAGCGAAGTTCTCATA
CTGCA-30), 417nM Molecular Beacon (FAM-CCCGCT
CGCTTATGCTACCGTGACCTGCGAATCCCGAGC
GGG-DABSYL, Biomers), 41.7U/ml recombinant Taq
polymerase (Fermentas) and 1.33mM ROX reference
(ROX-TTTTTTT, Biomers). A two-step qPCR was run
with initial denaturation at 95 C for 5min, followed by
15s denaturation at 95 C; and 1min annealing/extension
at 60 C for 45 cycles. Raw real-time PCR proﬁles are
shown in Supplementary Figure S1.
RESULTS AND DISCUSSION
Proximity extension assay
We have previously developed a highly sensitive and spe-
ciﬁc protein detection method based on antibodies coupled
to DNA oligos (proximity probes) (1,2). Proximity probes
joined with a DNA ligase can in some cases suffer from
recovery loss in some complex biological ﬂuids, such as
blood plasma (3). Therefore, we set out to develop a new
method for protein detection not based on DNA ligases
but instead based on a proximity-dependent DNA poly-
merization event taking place between the two proximity
probes (Figure 1). Antibodies [either two matched mono-
clonal antibody (mAb), or one batch of polyclonal anti-
body (pAb) split in two fractions] are covalently linked
with two different 40-mer oligonucleotides, one being at-
tached at the 30-end, and the other at the 50-end (for details
on the sequence design, see ‘Materials and Methods’
section and Supplementary Table SI). To the 30-linked
probe, a 56-mer DNA oligo comprising 40-nt complemen-
tary to that probe, a 7-nt spacer and 9-nt complementary
to the corresponding 50-linked probe is hybridized. Next,
the hybridized proximity probe pair is incubated with a
sample containing the antigen of interest. This results in
binding between the proximity probe pair and the antigen,
and as a result, the oligonucleotides come in close prox-
imity and are hybridized to each other. The addition of a
DNA polymerase leads to an extension of the hybridiz-
ing oligo over the other probe arm. Finally, the DNA
e102 Nucleic Acids Research, 2011,Vol.39, No. 15 PAGE 2 OF 8template generated can be detected and quantiﬁed by
qPCR.
To enable an effective hot start when using native Taq
DNA polymerase in the qPCR reaction, some primer
pairs where designed as hairpins with limited stability,
thereby not exposing free 30-ends at room temperature
during reaction set up (9). The hairpin comprised 6nt of
the 30-end, and 6nt of the 50-end of each primer (see
‘Material and Methods’ section).
To optimize the sensitivity of the PEA reaction, differ-
ent designs of the extension primer were evaluated, in this
experiment using T4 DNA polymerase. This included
varying the length of the sequence being complementary
to the 50-linked probe (n=7–11) as shown in Figure 2A.
The extension primer that generated high signal, enabling
robust qPCR data, in combination with good sensitivity
for detecting different analytes was chosen for the experi-
ments presented below. The selected primer had a 9-nt
sequence complementary to the 50-linked probe. The
PEA reaction was further optimized by varying the salt
concentrations and comparing different reaction tempera-
tures (data not shown).
Below, a detailed characterization and evaluation of the
PEA method are described. Immunoassay parameters
including sensitivity, precision, recovery, speciﬁcity, assay
range and detectability in plasma are assessed for several
analytes.
Exonuclease activity reduces non-speciﬁc background and
improves assay sensitivity
An experiment was designed to assess whether 30!50
exonuclease activity possessed by some polymerases can
affect the extension reaction. We investigate the signal-
to-noise ratio for the detection of 50pM interleukin-8
(IL-8). T4 DNA Polymerase, DNA Polymerase I,
Klenow Fragment, Klenow Fragment exo
  were used in
the extension reaction, and compared with respect to the
resulting signal-to-background for IL-8 detection. When
using DNA polymerases that have a 30!50 exonuclease ac-
tivity (T4 DNA Polymerase, DNA Polymerase I, Klenow
Fragment), there was a clear difference in signal relative to
the background (Figure 2B). In contrast, the Klenow
Fragment lacking exonuclease activity (Klenow exo
 )
generated a much higher background than the Klenow
Fragment (Klenow exo
+). By adding Exonuclease I to
the Klenow Fragment exo
  reaction, the background
was lowered and, thereby, the signal-to-noise level was re-
stored. This showed that the reduced background observed
with the Klenow exo
+compared to Klenow exo
  was due
to the exonuclease activity and not due to intrinsic differ-
ences between the polymerases. The increased sensitivity
observed for exonuclease-able assays, can be explained by
a degradation of the free non-proximal DNA ends, which
prevent them from accumulating extension products over
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Figure 2. Exonuclease activity and hybridization length affects assay sensitivity. (A) VEGF assays were designed with different lengths of the
hybridization site and compared with respect to sensitivity. A 9-nt hybridization site was found to give the best signal-to-noise levels and was
selected for further studies. (B) Different DNA polymerases were tested with regards to their ability to generate good sensitivity in an IL-8-speciﬁc
assay. T4 DNA polymerase I, DNA polymerase I and Klenow fragment exo
+all possess a 30!50 exonuclease activity and performed well in the IL-8
detection. Klenow fragment exo
 , on the other hand, generated a background signal that was almost at the level of the antigen-induced signal. When
exogenous Exonuclease I was added to the reaction, the signal-to-noise level was restored.
Figure 1. Schematic description of the PEA. Upon sample incubation, the proximity probe pair binds its speciﬁc antigen. As a result, the probe
oligos come in close proximity and hybridize to each other. The addition of a DNA polymerase leads to an extension of the hybridizing oligo.
Finally, this results in a DNA template that can be detected and quantiﬁed by qPCR.
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occurring during the extension reaction.
DNA polymerase I and T4 DNA polymerase were the
most potent polymerases for this assay, based on the
signal-to-noise levels. However, the recovery in plasma
was generally somewhat lower for DNA polymerase I
(Figure 2B; and data not shown). Therefore, T4 DNA
polymerase was selected for the remaining experiments
of this study. Two additional DNA polymerases, T7 and
phi-29, were also tested in this initial experimental setup.
These enzymes generated a much lower signal over all, and
were therefore not considered for further studies (data not
shown). However, both of these polymerases possess a
strong 30!50 exonuclease activity, and should still be con-
sidered as potential candidates for PEA and could beneﬁt
from further optimization of their speciﬁc reaction
conditions.
Precision, recovery and detection of low-abundant analytes
in blood plasma
One of the major challenges in biomarker research is to
develop highly sensitive methods that allow for the detec-
tion of proteins present only in minute amounts in bio-
logical samples. Therefore, we examined the ability of
PEA to accurately detect low-abundant proteins in a
complex matrix, human EDTA-prepared plasma, using
the 30!50 exonuclease-efﬁcient T4 DNA polymerase.
Human IL-8 was spiked at increasing concentrations
into either a non-complex matrix, PBS with 0.1% BSA,
or into plasma and quantiﬁed by PEA (Figure 3A). As a
second example, the human protein glial cell line-derived
neurotrophic factor (GDNF) was spiked into human
plasma (Figure 3B). The sensitivity of both assays was
found to be very good. Both analytes were detected and
could be quantiﬁed at concentrations as low as 0.1pM. In
fact, the signal-to-noise for the GDNF detection at 0.1pM
was more than eight times over background. This suggests
that even lower concentrations of GDNF would be detect-
able. The detection dynamic range of these IL-8 and
GDNF assays spanned at least four orders of magnitude
(between 0.1 and 100pM), and the lower limit of detection
(2  SD above buffer background) for was determined to
48 and 9fM, respectively. Both proteins are of very low
abundance (low picomolar) in plasma and therefore difﬁ-
cult to detect with some standard technologies (10,11).
Despite this, both analytes were readily detected in
human blood plasma demonstrating the sensitivity of
PEA. In addition, as PEA consumes only 1ml of sample
for analysis, it is highly suitable for biomarker research
studies when clinical samples often are in shortage.
Another critical parameter to study in immunoassay
evaluations is precision. To address the intraassay vari-
ation, the experiments in Figure 3 were run using triplicate
samples. The average coefﬁcient of variation (CV) across
all concentrations was 11 and 14% for the two assays,
respectively. This was similar to the results observed for
PLA, for which an average CV of 11% was determined for
a set of around 70 PLA assays (3).
Recovery (the difference in signal between a complex
and a non-complex matrix) reﬂects the ability of an
assay to accurately quantify an analyte in biological ma-
terials. As mentioned above, we and others have previous-
ly used PLA to detect a number of biomarkers in blood
plasma (3,12–14). However, the activity of DNA ligase
utilized in these assays was impaired in blood plasma,
sometimes resulting in poor recovery (3). The average
recovery determined for 13 PLA assays was only 33%
(data not shown). By performing those PLA assays in
multiplex, and using an exogenous spike-in normalizer,
the recovery issue was solved. However, for measurements
of single markers, PLA was still unsatisfactory. The T4
DNA polymerase used in the current PEA reaction
seemed to perform well in blood plasma. At concentra-
tions between 1pM and 1nM, the average recovery for
IL-8 and GDNF was as high as 81 and 110%, respectively
(Figure 3). It should be emphasized that these results were
obtained without any optimization of the speciﬁc buffer
conditions for each probe/target binding, which is
standard procedure in immunoassay development. When
IL-8 and GDNF were analyzed previously with PLA with
the recovery was signiﬁcantly lower; 18 and 24%, respect-
ively (data not shown). This is a demonstrated a signiﬁ-
cant improvement compared to the PLA, allowing for
accurate analyte quantiﬁcation without the need for
internal normalizations.
Enhancement of PEA performance through increased
target binding upon water exclusion
Target binding in this homogeneous immunoassay is de-
pendent on the probe concentration and their target
afﬁnity (2). In an ideal homogeneous proximity assay,
one would like to have a high probe concentration
during sample incubation to drive probe/target binding.
This incubation is subsequently diluted prior to the exten-
sion reaction in order to lower the probability of random
proximity events. The ratio of probe concentration during
incubation versus extension should be as high as possible
but still within practical limits and provide sufﬁcient
amounts of template for the qPCR to maintain its robust-
ness. Thus, simply raising the probe concentration during
incubation would increase the background signal due to
increased chances for random events of proximity. To get
around this, the effective probe concentration was artiﬁ-
cially raised by macro-molecular crowding, and the PEA
performance was re-evaluated for a number of assays. Dry
sephadex beads can upon rehydration in water expand
and thereby also take up water into the beads while
larger molecules, such as proteins and proximity probes,
would remain outside the beads and thereby effectively
enhance their concentrations and promote target binding
(7). To test this, 500mg of sephadex G10, G25, G100,
G150 or G200 was lyophilized at the bottom of the PEA
incubation tubes onto which the probe mix and a sample
containing three different concentrations of ICAM were
added, followed by a regular PEA protocol. This experi-
ment demonstrated that while G10 to G50 did not affect
the assay performance, the inclusion of G100, G150 or
G200 led to a dramatic increase in signal (Figure 4A).
G100 was found to give the best signal-to-noise levels at
all antigen concentrations, most likely due to its high
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G150 and G200. Next, a complete standard curve was
generated for ICAM and analyzed with or without
sephadex G100 present during the incubation step. This
revealed dramatic improvements in speciﬁc target binding
seen as enhanced sensitivity (Figure 4B). Most striking
was the dramatic increase in signal-to-noise level
obtained for the lowest antigen concentration.
To study whether other assays would beneﬁt from the
sephadex G100 incubation, a panel of 15 different ana-
lytes were tested in multiplex. This data are displayed in
Figure 4C in which the change in signal-to-noise upon
sephadex G100 inclusion (ddCt) is plotted as a function
of the signal-to-noise for each assay (dCt). Five assays
were improved in the presence of G100, three assays were
impaired and seven remained unchanged. The reduced
sensitivity observed for some assays was due to a substan-
tial increase of their background signals. Such background
increase could occur if the two proximity probes have a
slight afﬁnity to each other. Overall, there was a trend that
less sensitive assays (lower antibody afﬁnities) seemed to
beneﬁt the most from water exclusion. Therefore, for
improved assay performance for a certain assay, enclosure
of G100 in the probe/target incubation step could be
worthwhile considering.
In clinical diagnostics, rapid protocols are highly desir-
able. Therefore, we assessed whether sephadex G100 in-
clusion could increase the rapidity of probe/target binding.
VEGF was spiked into buffer at 100pM and PEA was
performed at different time points after incubation
(1,10,30 and 60min). This demonstrated that when
G100 was present during the incubation, the signal was
signiﬁcant already after 1min of incubation, when
compared to reactions lacking G100 (Figure 4D).
Furthermore, already after 10min of incubation as much
as 80% of the maximum signal-to-noise was detected for
the G100 reaction, compared to 20% for reactions lacking
G100. All-in-all, these analyses bring forward macro-
molecular crowding as a way to improve both assay
sensitivity and velocity.
Speciﬁcity and detection in plasma
One of the hallmarks of both PEA and PLA is the require-
ment for dual and proximal binding of the PEA probes. In
theory, this should reduce any signal derived from non-
speciﬁc antibody binding. The standard curves of IL-8 and
GDNF (Figure 3) indicate very low limit of detection even
in plasma, indicating that the proximity probes are
binding speciﬁcally even in very complex samples that
contain a broad repertoire of proteins.
We generated 4 panels of 23 different assays using
analyte-speciﬁc sequences and ran the PEA in multiplex
(Supplementary Table S1). The performance of singleplex
PEA was compared to that of multiplex analysis for IL-8,
GDNF, CAIX and IL-17. A key feature of these multi-
plexed assays is that antibody cross reactivity will not
result in a non-speciﬁc signal since each probe carries a
unique DNA sequence and the generated DNA reporters
operate independently. This is evidenced by the similarity
of the standard curves generated with singleplex or multi-
plex PEA analysis (Figure 5).
Assay linearity was also assessed using multiplex PEA.
Four panels were generated each comprising 23 PEA
assays: one with high-abundant, two with low-abundant
A
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Figure 3. Detection of low-abundant analytes in human blood plasma. Assays were generated for human IL-8 (A) and GDNF (B). Buffer or a blood
plasma sample were spiked with either IL-8 or GDNF at concentrations between 0.1pM and 10nM, and measured with PEA. Signal is plotted as Ct
values. Both IL-8 and GDNF, two low-abundant analytes, were detectable in plasma. Both assays showed a good sensitivity with the lower detection
limit at, or below, 0.1pM.
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measured in blood plasma at three different dilutions,
and a buffer background control sample. Dilutions were
5-fold, corresponding to a 2.3 theoretical Ct decrease for
each dilution. Linearity was found to be good for
both high and low PEA signals, for both low-abundant
(Figure 6A; DcR3, IL-17, Her2, CA IX, IL-6, PSA),
mid-abundant (Figure 6B; PDGF BB, TFF3, CA19-9,
Spondin-2, EPCAM, NSE) and high-abundant markers
(Figure 6C; Cystatin C, Tenascin C, sVCAM, PAI-1,
MMP-9, MMP-2). This demonstrates that PEA is
well-suited for the analyses of a broad range of analytes
present in blood plasma and highlights the multiplexing
capacity of PEA.
CONCLUSION
In an attempt to improve the assay performance in
complex biological samples, two main enhancements on
nucleic acid proximity-based protein detection assays were
developed and evaluated. First, a DNA polymerase per-
forming a proximity-dependent DNA polymerization
forming the qPCR amplicon is used instead of using a
DNA ligase. DNA polymerases proved to be less prone
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serum in comparison to DNA ligases, thereby improving
assay recovery. Second, the choice of polymerase was
found crucial for the assay sensitivity. We found that
30!50 exonuclease activity exhibited by certain DNA
polymerases is important for this type of assay as they
reduce the background by degrading remaining
non-proximal DNA strands. We also discovered that for
some assays, in particular those with lower sensitivity, the
inclusion of sephadex G100 in the probe/target incubation
signiﬁcantly increased the assay sensitivity and rapidity.
All-in-all, PEA was found to perform well in plasma
with regards to sensitivity, speciﬁcity, precision and
dynamic range. Furthermore, PEA possess several advan-
tages when compared to other immunoassays, including a
fast and simple experimental protocol, multiplexing
capacity, low sample consumption (1ml) and the ability
to use lower afﬁnity antibodies without the need for opti-
mizations of speciﬁc reaction conditions. We anticipate
this method to contribute to biomarker research, espe-
cially for analysis of low-abundant proteins in precious
and limited biobanked human samples, laboratory animals
and other situations when only very small sample volumes
are available.
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